Will the total venture capital investment in U.S. biotech and pharmaceutical companies exceed $40 billion in 2024?

A 'breakthrough moment' in medical innovation typically attracts substantial investment. This question assesses whether the financial sector reflects this optimism with a significant increase in venture capital funding for biotech and pharma companies in the U.S. during 2024.

Implied probability (Yes)

60%

Closes

2026-09-03